Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media

Patent 6001870 Issued on December 14, 1999. Estimated Expiration Date:

September 30, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Treatment of fungal infections
Patent #: 4790989
Issued on: 12/13/1988
Inventor: Hunter , et al.

Pharmaceutical composition
Patent #: 4879287
Issued on: 11/07/1989
Inventor: Orr, et al.

Crystalline calcium pseudomonate
Patent #: 4916155
Issued on: 04/10/1990
Inventor: Baker, et al.

Polymorphs of crystalline mupirocin Patent #: 5594026
Issued on: 01/14/1997
Inventor: Greenway, et al.

Inventor

Henkel, Timothy John

Assignee

Application

No. 940730 filed on 09/30/1997

US Classes:

514/460, Chalcogen bonded directly to ring carbon of the hetero ring424/434, Mucosal (e.g., nasal, etc.)514/956Aural or otic (i.e., ear)

Examiners

Primary: Rose, Shep K.

Attorney, Agent or Firm

Venetianer; Stephen, Kinzig; Charles M., King; William T.

Foreign Patent References

0 069 423 EP 01/13/1983
0 095 897 EP 12/13/1983
0 167 856 EP 01/13/1986
231621 EP. 08/13/1987
251434 EP. 01/13/1988
WO 84/02076 WO 06/13/1984
WO9510999 WO. 04/13/1995
WO 95/10999 WO 04/13/1995
WO9814189 WO. 04/13/1998

International Classes

A61K 031/35
A61K 009/06
A61K 009/10
A61K 009/107

Foreign Application Priority Data

1997-08-09 GB

Abstract

Mupirocin or a salt or ester thereof may be used to treat recurrent sinusitis and recurrent otitis, in particular with novel spray or cream formulations adapted for administration to the nasopharynx.

Other References

Bertino et al Am. J. Health-Syst. Pharm. 54(19): 2185-2191, 1997
Naka Gawa et al Kagaku Ryohono Ryoiki 12(9): 1659-1667, 1995
Anon: J. Am Soc. Nephrol. 7(11): 2403-2408, 1996
Nakagawa et al Kagaku Ryohono Ryoiki 12(7): 1293-1296, 1996
Finlay et al Antimicrob. Agents Chemotherapy 41(5): 1137-1139, 1997
Nakamichi et al Yakurito Chiryo 24(1): 85-92, 1996
Raz, Raul et al Arch Intern. Med. 156(10): 1109-1112, 1996
Bloom et al Am. J. Kidney Dis. 27(5): 687-694, 1996
Nsouli, et al., "Nasal Topical Antimicrobial Agent, Mupirocin-(Bactroban), in the Prophylaxis of Repeated Paranasal Sinusitis (RPS): A Double Blind Placebo Control Study", Annals. of Allergy, Asthma and Immunology, vol. 76(1): pp. 117, (1996)
"Mupirocin", Merk Index, 11th edn., pp. 993, (1989